iTeos Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized from Q4 2019 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
iTeos Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2019 to Q3 2022.
  • iTeos Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending September 30, 2022 was 10M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 10M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 10M 0 0% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 10M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 0 0 Dec 31, 2021 10-Q 2022-11-10
Q3 2021 10M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 10M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 10M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 0 0 Dec 31, 2020 10-K 2022-03-23
Q3 2020 10M Sep 30, 2020 10-Q 2020-11-12
Q4 2019 0 Dec 31, 2019 10-K 2021-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.